Leukocyte immunoglobulin-like receptor: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 11: | Line 11: | ||
*LIR-1 | *LIR-1 | ||
**[[1g0x]], [[1ufu]] – hLIR ligand-binding domain D1D2– human <br /> | **[[1g0x]], [[1ufu]] – hLIR-1 ligand-binding domain D1D2– human <br /> | ||
**[[1ugn]], [[1vdg]] – hLIR ligand-binding domain D1D2 (mutant) <br /> | **[[1ugn]], [[1vdg]] – hLIR-1 ligand-binding domain D1D2 (mutant) <br /> | ||
**[[4ll9]] – hLIR ligand-binding domain D3D4 <br /> | **[[4ll9]] – hLIR-1 ligand-binding domain D3D4 <br /> | ||
*LIR-2 | |||
**[[4lla]] – hLIR-2 ligand-binding domain D3D4 <br /> | |||
**[[2otp]] – hLIR-2 ligand-binding domain D1D2 <br /> | |||
**[[2dyp]] – hLIR-2 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + H2A peptide<br /> | |||
*LIR-4 | |||
**[[3q2c]] – hLIR-4 N-terminal domain <br /> | |||
*LIR-5 | |||
**[[3p2t]] – hLIR-5 ligand-binding domain D1D2 <br /> | |||
*LIR-1 complexes | *LIR-1 complexes | ||
**[[1p7q]] – hLIR ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + POL polyprotein peptide<br /> | **[[1p7q]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + POL polyprotein peptide<br /> | ||
**[[3d2u]] – hLIR ligand-binding domain D1D2 + herpesvirus UL18 + β-2 microglobulin + actin peptide<br /> | **[[5knm]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + peptide<br /> | ||
**[[4no0]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + lymphocyte-specific protein peptide<br /> | |||
**[[3d2u]] – hLIR-1 ligand-binding domain D1D2 + herpesvirus UL18 + β-2 microglobulin + actin peptide<br /> | |||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 10:04, 4 July 2017
Leukocyte immunoglobulin-like receptors (LIR) or CD85 have extracellular immunoglobulin domains. LIR modulates a variety of immune cells. LIR interacts with class I MHC molecules[1]. |
| ||||||||||
3D structures of leukocyte immunoglobulin-like receptor3D structures of leukocyte immunoglobulin-like receptor
Updated on 04-July-2017
ReferencesReferences
- ↑ Thomas R, Matthias T, Witte T. Leukocyte immunoglobulin-like receptors as new players in autoimmunity. Clin Rev Allergy Immunol. 2010 Apr;38(2-3):159-62. doi:, 10.1007/s12016-009-8148-8. PMID:19548123 doi:http://dx.doi.org/10.1007/s12016-009-8148-8